IWAKI & CO., LTD., a leading specialized pharmaceutical trading company, has announced today its acquisition of Jitsubo CO., LTD., a pharmaceutical venture with unique liquid phase peptide manufacturing technology, Molecular Hiving™, through its 100% subsidiary, SPERA PHARMA, Inc. a CMC R&D contract company. With this transaction, Jitsubo has become 100% subsidiary of SPERA PHARMA.

More Details(PDF)